Seven studies included data on the outcome index of IFN-γ; the SMD was 1.90 (95% CI: 1.27–2.52; P <0.001), again showing increased circulating levels of IFN-γ in psoriasis patients compared to the control groups (Fig S4 in S1 File). Here, IFNG is linked to psoriasis.